Anti-idiotypic anti-TNF antibodies and related immunoassay methods
US7101674B2 · kind B2 · utility
23Cited by
21References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 2, 2001 |
| Grant date | Sep 5, 2006 |
| Priority date | — |
| Expiry date | Feb 27, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Anti-TNF antibodies and anti-TNF peptides, specific for tumor necrosis factor (TNF) are useful for in vivo diagnosis and therapy of a number of TNF-mediated pathologies and conditions, as well as polynucleotides coding for anti-TNF murine and chimeric antibodies, peptides, methods of making and using the antibody or peptides in immunoassays and immuno-therapeutic approaches are provided, where the anti-TNF peptide is selected from a soluble portion of TNF receptor, an anti-TNF antibody or structural analog thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.